Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AAL vs GSK✓SelectedUSD · GSKAAL vs GSK performance historyLatest closeAs of+0.70%11/18
Stock and ETF performance explorer

AAL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-70.9%
GSK return
+101.2%
Excess return
-172.1%
Maximum drawdown
-84.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.0%+1.2%
7D-7.7%-3.1%-4.6%-6.6%
30D+11.4%-0.9%+12.3%+11.8%
3M-7.4%-4.2%-3.2%-6.0%
6M+5.3%-1.6%+6.8%+5.4%
YTD-15.1%+2.6%-17.7%-16.3%
1Y+5.3%+6.2%-1.0%+2.4%
3Y+5.9%+55.0%-49.1%-15.2%
5Y-32.9%+42.8%-75.7%-45.0%
10Y-70.9%+102.1%-173.0%-79.3%
All-70.9%+101.2%-172.1%-79.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling